Ravindra Majeti (Ravi Majeti)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 48

Top Topics

Acute Myeloid Leukemia

Helicobacter Pylori Infection

Top Venues

Blood cancer discovery

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Kumiko Chino, Asiri Saumya Ediriwickrema, Brooks A Benard, Andrew J Gentles, Ross L Levine, Niko Beerenwinkel, Koichi Takahashi, Ravindra Majeti
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia 38 (7) (2024)
Thomas Kohnke, Kevin A Nuno, Catherine C Alder, Eric J Gars, Paul Phan, Amy C Fan, Ravindra Majeti
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. Blood cancer discovery 5 (3) (2024)
Thomas Kohnke, Kevin A Nuno, Catherine C Alder, Eric J Gars, Paul Phan, Amy C Fan, Ravindra Majeti
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. Blood cancer discovery 5 (3) (2024)
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn, Molly Javier Uyeda, Pauline Ping Chen, Yusuke Nakauchi, Colin Waichler, Norman J Lacayo, Rosa Bacchetta, Ravindra Majeti, Andrew J Gentles, Alma-Martina Cepika, Maria Grazia Roncarolo
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML. Leukemia 38 (6) (2024)
Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Kumiko Chino, Asiri Saumya Ediriwickrema, Brooks A Benard, Andrew J Gentles, Ross L Levine, Niko Beerenwinkel, Koichi Takahashi, Ravindra Majeti
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia 38 (7) (2024)
Fabian P Suchy, Daiki Karigane, Yusuke Nakauchi, Maimi Higuchi, Jinyu Zhang, Katja Pekrun, Ian Hsu, Amy C Fan, Toshinobu Nishimura, Carsten T Charlesworth, Joydeep Bhadury, Toshiya Nishimura, Adam C Wilkinson, Mark A Kay, Ravindra Majeti, Hiromitsu Nakauchi
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors. Nature biotechnology (2024)
Kevin A Nuno, Armon Azizi, Thomas Koehnke, Caleb A Lareau, Asiri Ediriwickrema, M Ryan Corces, Ansuman T Satpathy, Ravindra Majeti
Convergent epigenetic evolution drives relapse in acute myeloid leukemia. eLife 13 (2024)
Kevin A Nuno, Armon Azizi, Thomas Koehnke, Caleb A Lareau, Asiri Ediriwickrema, M Ryan Corces, Ansuman T Satpathy, Ravindra Majeti
Convergent epigenetic evolution drives relapse in acute myeloid leukemia. eLife 13 (2024)
Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Kumiko Chino, Asiri Saumya Ediriwickrema, Brooks A Benard, Andrew J Gentles, Ross L Levine, Niko Beerenwinkel, Koichi Takahashi, Ravindra Majeti
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia 38 (7) (2024)
Kevin A Nuno, Armon Azizi, Thomas Koehnke, Caleb A Lareau, Asiri Ediriwickrema, M Ryan Corces, Ansuman T Satpathy, Ravindra Majeti
Convergent epigenetic evolution drives relapse in acute myeloid leukemia. eLife 13 (2024)
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn, Molly Javier Uyeda, Pauline Ping Chen, Yusuke Nakauchi, Colin Waichler, Norman J Lacayo, Rosa Bacchetta, Ravindra Majeti, Andrew J Gentles, Alma-Martina Cepika, Maria Grazia Roncarolo
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML. Leukemia 38 (6) (2024)
Thomas Kohnke, Kevin A Nuno, Catherine C Alder, Eric J Gars, Paul Phan, Amy C Fan, Ravindra Majeti
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. Blood cancer discovery 5 (3) (2024)
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn, Molly Javier Uyeda, Pauline Ping Chen, Yusuke Nakauchi, Colin Waichler, Norman J Lacayo, Rosa Bacchetta, Ravindra Majeti, Andrew J Gentles, Alma-Martina Cepika, Maria Grazia Roncarolo
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML. Leukemia 38 (6) (2024)
Thomas Kohnke, Kevin A Nuno, Catherine C Alder, Eric J Gars, Paul Phan, Amy C Fan, Ravindra Majeti
Human ASXL1-mutant hematopoiesis is driven by a truncated protein associated with aberrant de-ubiquitination of H2AK119. Blood cancer discovery (2024)
Kevin A Nuno, Armon Azizi, Thomas Koehnke, Caleb A Lareau, Asiri Ediriwickrema, M Ryan Corces, Ansuman T Satpathy, Ravindra Majeti
Convergent epigenetic evolution drives relapse in acute myeloid leukemia. eLife 13 (2024)
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn, Molly Javier Uyeda, Pauline Ping Chen, Yusuke Nakauchi, Colin Waichler, Norman J Lacayo, Rosa Bacchetta, Ravindra Majeti, Andrew J Gentles, Alma-Martina Cepika, Maria Grazia Roncarolo
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML. Leukemia (2024)
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn, Molly Javier Uyeda, Pauline Ping Chen, Yusuke Nakauchi, Colin Waichler, Norman J Lacayo, Rosa Bacchetta, Ravindra Majeti, Andrew J Gentles, Alma-Martina Cepika, Maria Grazia Roncarolo
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML. Leukemia 38 (6) (2024)
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn, Molly Javier Uyeda, Pauline Ping Chen, Yusuke Nakauchi, Colin Waichler, Norman J Lacayo, Rosa Bacchetta, Ravindra Majeti, Andrew J Gentles, Alma-Martina Cepika, Maria Grazia Roncarolo
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML. Leukemia 38 (6) (2024)
Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Kumiko Chino, Asiri Saumya Ediriwickrema, Brooks A Benard, Andrew J Gentles, Ross L Levine, Niko Beerenwinkel, Koichi Takahashi, Ravindra Majeti
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia (2024)
Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Kumiko Chino, Asiri Saumya Ediriwickrema, Brooks A Benard, Andrew J Gentles, Ross L Levine, Niko Beerenwinkel, Koichi Takahashi, Ravindra Majeti
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia (2024)
Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Kumiko Chino, Asiri Saumya Ediriwickrema, Brooks A Benard, Andrew J Gentles, Ross L Levine, Niko Beerenwinkel, Koichi Takahashi, Ravindra Majeti
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia (2024)
Niklas Landberg, Thomas Kohnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation. Blood cancer discovery (2024)
Kevin A Nuno, Armon Azizi, Thomas Koehnke, Caleb A Lareau, Asiri Ediriwickrema, M Ryan Corces, Ansuman T Satpathy, Ravindra Majeti
Convergent epigenetic evolution drives relapse in acute myeloid leukemia. eLife 13 (2024)
Fabian P Suchy, Daiki Karigane, Yusuke Nakauchi, Maimi Higuchi, Jinyu Zhang, Katja Pekrun, Ian Hsu, Amy C Fan, Toshinobu Nishimura, Carsten T Charlesworth, Joydeep Bhadury, Toshiya Nishimura, Adam C Wilkinson, Mark A Kay, Ravindra Majeti, Hiromitsu Nakauchi
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors. Nature biotechnology (2024)
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn, Molly Javier Uyeda, Pauline Ping Chen, Yusuke Nakauchi, Colin Waichler, Norman J Lacayo, Rosa Bacchetta, Ravindra Majeti, Andrew J Gentles, Alma-Martina Cepika, Maria Grazia Roncarolo
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML. Leukemia (2024)
Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Kumiko Chino, Asiri Saumya Ediriwickrema, Brooks A Benard, Andrew J Gentles, Ross L Levine, Niko Beerenwinkel, Koichi Takahashi, Ravindra Majeti
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia 38 (7) (2024)
Ravindra Majeti, Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde Miles, Robert Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Kumiko Chino, Asiri Saumya Ediriwickrema, Brooks A Benard, Andrew J Gentles, Ross L Levine, Niko Beerenwinkel, Koichi Takahashi
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Research square (2023)
Niklas Landberg, Thomas Kohnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation. Blood cancer discovery (2023)
Miles H Linde, Amy C Fan, Thomas Kohnke, Aaron C Trotman-Grant, Sarah F Gurev, Paul Phan, Feifei Zhao, Naomi L Haddock, Kevin A Nuno, Eric J Gars, Melissa Stafford, Payton L Marshall, Christopher G Dove, Ian L Linde, Niklas Landberg, Lindsay P Miller, Robbie G Majzner, Tian Yi Zhang, Ravindra Majeti
Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy. Cancer discovery (2023)
Andriana G Kotini, Saul Carcamo, Nataly Cruz-Rodriguez, Malgorzata Olszewska, Tiansu Wang, Deniz Demircioglu, Chan-Jung Chang, Elsa Bernard, Mark P Chao, Ravindra Majeti, Hanzhi Luo, Michael Gregory Kharas, Dan Hasson, Eirini P Papapetrou
Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia. Blood cancer discovery (2023)
Annika Nelde, Heiko Schuster, Jonas S Heitmann, Jens Bauer, Yacine Maringer, Melissa Zwick, Jens-Peter Volkmer, James Y Chen, Anna M Paczulla Stanger, Ariane Lehmann, Bismark Appiah, Melanie Märklin, Elke Rücker-Braun, Helmut R Salih, Malte Roerden, Sarah M Schroeder, Max-Felix Häring, Andreas Schlosser, Johannes Schetelig, Marc Schmitz, Melanie Börries, Natalie Stickel, Claudia Lengerke, Ravindra Majeti, Irving L Weissman, Hans-Georg Rammensee, Juliane Sarah Walz
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells. Blood cancer discovery (2023)
Daniel Thomas, Manhong Wu, Yusuke Nakauchi, Ming Zheng, Chloe A L Thompson-Peach, Kelly Lim, Niklas Landberg, Thomas Kohnke, Nirmal Robinson, Satinder Kaur, Monika M Kutyna, Melissa Stafford, Devendra K Hiwase, Andreas Reinisch, Gary Peltz, Ravindra Majeti
Dysregulated lipid synthesis by oncogenic IDH1 mutation is a targetable synthetic lethal vulnerability. Cancer discovery (2022)
Naval G Daver, Abhishek Maiti, Tapan Mahendra Kadia, Paresh Vyas, Ravindra Majeti, Andrew H Wei, Guillermo Garcia Manero, Charles F Craddock, David A Sallman, Hagop M Kantarjian
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. Cancer discovery 12 (11) (2022)
Mahmoud Adel Bassal, Saumya E E Samaraweera, Kelly Lim, Brooks A Benard, Sheree Bailey, Satinder Kaur, Paul Leo, John Toubia, Chloe A L Thompson-Peach, Tran Nguyen, Kyaw Ze Ya Maung, Debora A Casolari, Diana G Iarossi, Ilaria S Pagani, Jason Powell, Stuart M Pitson, Siria Natera, Ute Roessner, Ian D Lewis, Anna L Brown, Daniel G Tenen, Nirmal Robinson, David M Ross, Ravindra Majeti, Thomas J Gonda, Daniel Thomas, Richard J J D'Andrea
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia. Nature communications 13 (1) (2022)
Nathaniel W Mabe, Min Huang, Guillermo N Dalton, Gabriela Alexe, Daniel A Schaefer, Anna C Geraghty, Amanda L Robichaud, Amy S Conway, Delan Khalid, Marius M Mader, Julia A Belk, Kenneth N Ross, Michal Sheffer, Miles H Linde, Nghi Ly, Winnie Yao, Maria Caterina Rotiroti, Benjamin A H Smith, Marius Wernig, Carolyn R Bertozzi, Michelle Monje, Constantine S Mitsiades, Ravindra Majeti, Ansuman T Satpathy, Kimberly Stegmaier, Robbie G Majzner
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1. Nature cancer 3 (8) (2022)
Yusuke Nakauchi, Armon Azizi, Daniel Thomas, M Ryan Corces, Andreas Reinisch, Rajiv Sharma, David Cruz Hernandez, Thomas Köhnke, Daiki Karigane, Amy C Fan, Daniel Martinez-Krams, Melissa Stafford, Satinder Kaur, Ritika Dutta, Paul Phan, Asiri Saumya Ediriwickrema, Erin McCarthy, Yuhong Ning, Tierney Phillips, Christopher K Ellison, Gulfem D Guler, Anna Bergamaschi, Chin-Jen Ku, Samuel Levy, Ravindra Majeti
The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia. Blood cancer discovery 3 (4) (2022)
Mahmoud Adel Bassal, Saumya E E Samaraweera, Kelly Lim, Brooks A Benard, Sheree Bailey, Satinder Kaur, Paul Leo, John Toubia, Chloe A L Thompson-Peach, Tran Nguyen, Kyaw Ze Ya Maung, Debora A Casolari, Diana G Iarossi, Ilaria S Pagani, Jason Powell, Stuart M Pitson, Siria Natera, Ute Roessner, Ian D Lewis, Anna L Brown, Daniel G Tenen, Nirmal Robinson, David M Ross, Ravindra Majeti, Thomas J Gonda, Daniel Thomas, Richard J J D'Andrea
Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia. Nature communications 13 (1) (2022)
Yu-Chen Lo, Timothy J Keyes, Astraea Jager, Jolanda Sarno, Pablo Domizi, Ravindra Majeti, Kathleen M Sakamoto, Norman Lacayo, Charles G Mullighan, Jeffrey Waters, Bita Sahaf, Sean C Bendall, Kara L Davis
CytofIn enables integrated analysis of public mass cytometry datasets using generalized anchors. Nature communications 13 (1) (2022)
Anna P Hnatiuk, Arne A N Bruyneel, Dhanir Tailor, Mallesh Pandrala, Arpit Dheeraj, Wenqi Li, Ricardo Serrano, Dries A M Feyen, Michelle M Vu, Prashila Amatya, Saloni Gupta, Yusuke Nakauchi, Isabel Morgado, Volker Wiebking, Ronglih Liao, Matthew H Porteus, Ravindra Majeti, Sanjay V Malhotra, Mark Mercola
Reengineering Ponatinib to Minimize Cardiovascular Toxicity. Cancer research 82 (15) (2022)
Johanna Theruvath, Marie Menard, Benjamin A H Smith, Miles H Linde, Garry L Coles, Guillermo Nicolas Dalton, Wei Wu, Louise Kiru, Alberto Delaidelli, Elena Sotillo, John L Silberstein, Anna C Geraghty, Allison Banuelos, Molly Thomas Radosevich, Shaurya Dhingra, Sabine Heitzeneder, Aidan Tousley, John Lattin, Peng Xu, Jing Huang, Nicole Nasholm, Andy He, Tracy C Kuo, Emma R B Sangalang, Jaume Pons, Amira Barkal, Rachel E Brewer, Kristopher D Marjon, Jose G Vilches-Moure, Payton L Marshall, Ricardo Fernandes, Michelle Monje, Jennifer R Cochran, Poul H Sorensen, Heike Elisabeth Daldrup-Link, Irving L Weissman, Julien Sage, Ravindra Majeti, Carolyn R Bertozzi, William A Weiss, Crystal L Mackall, Robbie G Majzner
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nature medicine 28 (2) (2022)
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M Bennett, Uma Borate, Andrew M Brunner, Hetty E Carraway, Jane E Churpek, Naval G Daver, Matteo Della Porta, Amy E DeZern, Fabio Efficace, Pierre Fenaux, Maria E Figueroa, Peter Greenberg, Elizabeth A Griffiths, Stephanie Halene, Robert P Hasserjian, Christopher S Hourigan, Nina Kim, Tae Kon Kim, Rami S Komrokji, Vijay Kutchroo, Alan F List, Richard F Little, Ravindra Majeti, Aziz Nazha, Stephen D Nimer, Olatoyosi Odenike, Eric Padron, Mirinal S Patnaik, Gail J Roboz, David A Sallman, Guillermo F Sanz, Maximilian Stahl, Daniel T Starczynowski, Justin Taylor, Zhuoer Xie, Mina L Xu, Michael R Savona, Andrew H Wei, Omar Abdel-Wahab, Valeria Santini
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes. Leukemia 36 (12) (2022)
Tian Yi Zhang, Ritika Dutta, Brooks Benard, Feifei Zhao, Raymond Yin, Ravindra Majeti
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia. Science translational medicine 12 (538) (2021)
M Kyle Cromer, Joab Camarena, Renata M Martin, Benjamin J Lesch, Christopher A Vakulskas, Nicole M Bode, Gavin L Kurgan, Michael A Collingwood, Garrett R Rettig, Mark A Behlke, Viktor T Lemgart, Yankai Zhang, Ankush Goyal, Feifei Zhao, Ezequiel Ponce, Waracharee Srifa, Rasmus O Bak, Naoya Uchida, Ravindra Majeti, Vivien A Sheehan, John F Tisdale, Daniel P Dever, Matthew H Porteus
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells. Nature medicine 27 (4) (2021)
Brooks A Benard, Logan B Leak, Armon Azizi, Daniel Thomas, Andrew J Gentles, Ravindra Majeti
Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia. Nature communications 12 (1) (2021)
Rajiv Sharma, Daniel P Dever, Ciaran M Lee, Armon Azizi, Yidan Pan, Joab Camarena, Thomas Köhnke, Gang Bao, Matthew H Porteus, Ravindra Majeti
The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells. Nature communications 12 (1) (2021)
Michael A Koldobskiy, Jordi Abante, Garrett Jenkinson, Elisabet Pujadas, Ashley Tetens, Feifei Zhao, Rakel Tryggvadottir, Adrian Idrizi, Andreas Reinisch, Ravindra Majeti, John Goutsias, Andrew P Feinberg
A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML. Epigenetics 15 (8) (2020)
Armon Azizi, Asiri Ediriwickrema, Ritika Dutta, Shyam A Patel, William Shomali, Bruno Medeiros, David Iberri, Jason Gotlib, Gabriel Mannis, Peter Greenberg, Ravindra Majeti, Tian Yi Zhang
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Leukemia & lymphoma 61 (11) (2020)
Toshinobu Nishimura, Haojun Xu, Masayuki Iwasaki, Daiki Karigane, Brandon Saavedra, Yusuke Takahashi, Fabian P Suchy, Shinichiro Monobe, Renata M Martin, Manami Ohtaka, Mahito Nakanishi, Scott R Burrows, Michael L Cleary, Ravindra Majeti, Akira Shibuya, Hiromitsu Nakauchi
Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells. Gene therapy 27 (10-11) (2020)